Case reportPublished 3 Oct 2018

Toxoplasma Gondii Encephalitis from Mycophenolate Mofetil: A Case Report and Review

Authors: Singer JL, De La Pena N

Archives of Medicine

Volume 10 · Issue 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Mycophenolate mofetil (MMF) is often used in the treatment of autoimmune diseases such as myasthenia gravis and the prevention of organ rejection after transplantation. Toxoplasma encephalitis (TE) is typically associated with human immunodeficiency virus (HIV) infection. We present a case of an HIV sero-negative woman who developed TE after long-term MMF therapy for the treatment of myasthenia gravis. TE can occur even with low doses of MMF. A high index of suspicion is needed for patients presenting with focal neurologic deficits given poor outcomes in the majority of reported cases. Prophylaxis against TE can be considered although further study is needed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Medicine
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Singer JL”
  • BylineArticles whose byline prints “De La Pena N”